Literature DB >> 33773892

Giant pulmonary hydatid cyst in children.

Alaa Aqqad1, Besma Hamdi2, Sabrine Louhaichi2, Ikbel Khalfallah2, Monia Attia3, Sarra Zairi4, Jamel Ammar2, Agnès Hamzaoui2.   

Abstract

BACKGROUND: Lungs are the second most common site for hydatid disease after the liver. Giant hydatid cyst (GHC) of the lung is a special clinical entity in children and is related to higher lung tissue elasticity. AIM: To compare clinical and imaging features, types of surgical interventions, and postoperative complications in pulmonary GHC and non-giant pulmonary hydatid cysts (NGHC) in children.
METHODS: A retrospective study was undertaken. The data analyzed were taken from medical records of children with pulmonary hydatid cyst (PHC) hospitalized in a pulmonary department in Tunisia between January 2004 and February 2019. Cysts were divided according to their size into GHC ( ≥10cm) and NGHC (<10cm).
RESULTS: In the study period, 108 PHC were recorded in 84 children. GHC accounted for 21 (19.4%) and NGHC for 87 (80.6%). The median of age of the children was 11 years (IQR 1-9, IQR 3-14) and the mean age was 11.6 years (10.5 in GHC vs. 11.4 years in NGHC). Hemoptysis was found in 25% of the GHC group vs. 48.4% of the NGHC group (P=0.27). Cysts were multiple in 23.8% of cases and predominated in the right in 64.3% of cases and in the inferior lobes in 71.4% of the cases. GHCs were less frequently complicated (60% vs. 78.1% in NGHC, P≤0.11), although not significantly. Parenchymal resection was realized in 50% of GHC vs. 18.8% of NGHC (P=0.006). No significant difference was found in postoperative complications between the two groups and there was no recurrence in either group.
CONCLUSION: GHC is a special clinical entity in children. It requires major surgery with parenchymal resection, and therefore early diagnostic and therapeutic management is warranted.
Copyright © 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cystectomy; Lobectomy; Pediatrics; Pulmonary hydatidosis; Tunisia

Mesh:

Year:  2021        PMID: 33773892     DOI: 10.1016/j.arcped.2021.02.017

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  1 in total

1.  Superior Vena Cava Syndrome Secondary to the Largest Reported Thoracic Hydatid Disease.

Authors:  Ali B Abdul Jabbar; Muhammad Ali; Muhammad Abdullah Arain; Sardar Shahmir B Chauhan; Saulat Fatimi
Journal:  Cureus       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.